NeuroMetrix (Nasdaq:NURO) today reported momentum in its strategic collaboration with GSK Consumer Healthcare. As quoted in the press release: Under terms of the collaboration entered into in the first quarter of 2018, the parties committed to co-fund future development of Quell® technology beginning in 2019, subject to agreement on an annual program of product initiatives. The … Continued